KR100535554B1 - 소아과 수술에서의 레보부피바카인의 용도 - Google Patents

소아과 수술에서의 레보부피바카인의 용도 Download PDF

Info

Publication number
KR100535554B1
KR100535554B1 KR10-1999-7007973A KR19997007973A KR100535554B1 KR 100535554 B1 KR100535554 B1 KR 100535554B1 KR 19997007973 A KR19997007973 A KR 19997007973A KR 100535554 B1 KR100535554 B1 KR 100535554B1
Authority
KR
South Korea
Prior art keywords
levobupivacaine
bupivacaine
hcl
administration
surgery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR10-1999-7007973A
Other languages
English (en)
Korean (ko)
Other versions
KR20000075894A (ko
Inventor
브라이언 알버트 제너리
Original Assignee
다윈 디스커버리 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다윈 디스커버리 리미티드 filed Critical 다윈 디스커버리 리미티드
Publication of KR20000075894A publication Critical patent/KR20000075894A/ko
Application granted granted Critical
Publication of KR100535554B1 publication Critical patent/KR100535554B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
KR10-1999-7007973A 1997-03-03 1998-03-03 소아과 수술에서의 레보부피바카인의 용도 Expired - Lifetime KR100535554B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9704351.7 1997-03-03
GBGB9704351.7A GB9704351D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
PCT/GB1998/000664 WO1998038999A1 (en) 1997-03-03 1998-03-03 The use of levobupivacaine in paediatric surgery

Publications (2)

Publication Number Publication Date
KR20000075894A KR20000075894A (ko) 2000-12-26
KR100535554B1 true KR100535554B1 (ko) 2005-12-08

Family

ID=10808602

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-1999-7007973A Expired - Lifetime KR100535554B1 (ko) 1997-03-03 1998-03-03 소아과 수술에서의 레보부피바카인의 용도

Country Status (20)

Country Link
US (1) US5910502A (cg-RX-API-DMAC10.html)
EP (1) EP0981348B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001513814A (cg-RX-API-DMAC10.html)
KR (1) KR100535554B1 (cg-RX-API-DMAC10.html)
CN (1) CN1107504C (cg-RX-API-DMAC10.html)
AT (1) ATE240731T1 (cg-RX-API-DMAC10.html)
AU (1) AU719483B2 (cg-RX-API-DMAC10.html)
BR (1) BR9808302A (cg-RX-API-DMAC10.html)
CA (1) CA2279498C (cg-RX-API-DMAC10.html)
DE (1) DE69814852T2 (cg-RX-API-DMAC10.html)
DK (1) DK0981348T3 (cg-RX-API-DMAC10.html)
ES (1) ES2199424T3 (cg-RX-API-DMAC10.html)
GB (1) GB9704351D0 (cg-RX-API-DMAC10.html)
HU (1) HU224227B1 (cg-RX-API-DMAC10.html)
IL (1) IL131086A0 (cg-RX-API-DMAC10.html)
NO (1) NO324215B1 (cg-RX-API-DMAC10.html)
PL (1) PL190896B1 (cg-RX-API-DMAC10.html)
PT (1) PT981348E (cg-RX-API-DMAC10.html)
WO (1) WO1998038999A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA981780B (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
AU2002359407B2 (en) * 2001-11-14 2008-02-28 Durect Corporation Catheter injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
ATE507816T1 (de) * 2001-11-14 2011-05-15 Durect Corp Injizierbare depotzusammensetzungen und deren verwendung
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
WO2004012703A1 (en) * 2002-07-31 2004-02-12 Alza Corporation Injectable depot compositions and uses thereof
CN1684663A (zh) * 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
CA2216583C (en) * 1995-04-13 2007-10-30 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Also Published As

Publication number Publication date
HK1022649A1 (en) 2000-08-18
HUP0000963A3 (en) 2000-10-30
ES2199424T3 (es) 2004-02-16
BR9808302A (pt) 2000-05-16
NO324215B1 (no) 2007-09-10
DK0981348T3 (da) 2003-09-15
HUP0000963A2 (hu) 2000-09-28
HU224227B1 (hu) 2005-06-28
NO994259L (no) 1999-11-02
DE69814852D1 (de) 2003-06-26
ATE240731T1 (de) 2003-06-15
ZA981780B (en) 1999-03-03
AU719483B2 (en) 2000-05-11
PT981348E (pt) 2003-09-30
CA2279498C (en) 2009-05-26
IL131086A0 (en) 2001-01-28
US5910502A (en) 1999-06-08
PL190896B1 (pl) 2006-02-28
CN1107504C (zh) 2003-05-07
EP0981348B1 (en) 2003-05-21
GB9704351D0 (en) 1997-04-23
PL335563A1 (en) 2000-05-08
JP2001513814A (ja) 2001-09-04
CA2279498A1 (en) 1998-09-11
WO1998038999A1 (en) 1998-09-11
KR20000075894A (ko) 2000-12-26
DE69814852T2 (de) 2004-01-22
NO994259D0 (no) 1999-09-02
AU6631098A (en) 1998-09-22
EP0981348A1 (en) 2000-03-01
CN1249683A (zh) 2000-04-05

Similar Documents

Publication Publication Date Title
CA2279498C (en) The use of levobupivacaine in paediatric surgery
KR100343314B1 (ko) 만성통증치료에유용한레보부피바카인
Hüter et al. Low-dose intravenous midazolam reduces etomidate-induced myoclonus: a prospective, randomized study in patients undergoing elective cardioversion
US5849763A (en) Use of levobupivacaine as an anesthetic agent
KR100516676B1 (ko) 안면 수술에서의 레보부피바카인의 용도
AU7859494A (en) Analgesic agent and its use
Lauretti et al. Intrathecal neostigmine for postoperative analgesia after orthopedic surgery
KR20150131330A (ko) 지속성 국소 마취용 네오삭시톡신 조합 제형
Boezaart et al. A comparison of propofol and remifentanil for sedation and limitation of movement during periretrobulbar block
CN1128620C (zh) 左布比卡因在制备治疗偏头痛的药物中的用途
JP3792251B2 (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
CA2165446C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
CA2454544A1 (en) Optic nerve protecting agents containing .alpha.1 receptor blocker as active ingredient
West et al. Sudden hypotension associated with midazolam and sufentanil
Fayed et al. Comparative study between effects of addition of fentanyl versus dexmedetomidine to local anesthetic mixture for peribulbar block for cataract surgery
Upadya et al. Anesthesia for dermatological surgery
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
Fathi et al. Carticaine versus lidocaine for peribulbar anesthesia in cataract surgery
MXPA99008057A (en) The use of levobupivacaine in paediatric surgery
HK1022649B (en) The use of levobupivacaine in paediatric surgery
Molnar Long-term treatment of spasticity in children with cerebral palsy
Naik et al. Study of Dexmedetomidine as intramuscular premedication in outpatient cataract surgery: A placebo–controlled study
CA2173207C (en) Levobupivacaine and its use as an anaesthetic in patients having or disposed to depressed myocardial contractility
CA2505487C (en) Levobupivacaine and its use as an anaesthetic in obstetrics
Kinross-Wright Succinylcholine in electroshock treatment

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19990902

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20030303

Comment text: Request for Examination of Application

E801 Decision on dismissal of amendment
PE0801 Dismissal of amendment

Patent event code: PE08012E01D

Comment text: Decision on Dismissal of Amendment

Patent event date: 20041213

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20030303

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20050221

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20050729

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20051018

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20051202

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20051201

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20081126

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20091123

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20101124

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20111122

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20121123

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20121123

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20131119

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20131119

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20141124

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20141124

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20151030

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20151030

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20161028

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20161028

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20171027

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20171027

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20180903

Termination category: Expiration of duration